ICD-10-CM C61 is the diagnosis code for Malignant neoplasm of prostate. This code falls under the section "Malignant neoplasms of male genital organs" within Chapter 2 — Neoplasms (C00-D49). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
The following conditions should never be coded at the same time as C61. They are mutually exclusive:
Understanding where C61 sits in the ICD-10-CM classification helps ensure proper coding:
Yes, C61 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
C61 is the ICD-10-CM diagnosis code for "Malignant neoplasm of prostate". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
C61 is located in Section C60-C63 — "Malignant neoplasms of male genital organs" within Chapter 2 of the ICD-10-CM Tabular List.
Use C61 when the patients documented diagnosis matches "Malignant neoplasm of prostate" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Malignant neoplasm of prostate is C61.
Yes, C61 can be used as a primary diagnosis code since it is billable and specific.
C61 is in Chapter 2 of the ICD-10-CM Tabular List.
Type 1 Excludes for C61 include: malignant neoplasm of seminal vesicle (C63.7).
Yes, C61 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.